Show simple item record

dc.contributor.authorBagwell, Sage
dc.contributor.authorLavitas, Pavel
dc.contributor.authorPomfret, Thomas C.
dc.contributor.authorGreenwood, Bonnie C.
dc.contributor.authorTrask, Nicole M.
dc.contributor.authorTran, Stephanie
dc.contributor.authorSchiff, Nancy L.
dc.contributor.authorHydery, Tasmina
dc.contributor.authorLeto, Patricia
dc.contributor.authorPrice, Mylissa K.
dc.contributor.authorAlper, Caroline J.
dc.contributor.authorLenz, Kimberly J.
dc.contributor.authorJeffrey, Paul L.
dc.date2022-08-11T08:08:07.000
dc.date.accessioned2022-08-23T15:42:53Z
dc.date.available2022-08-23T15:42:53Z
dc.date.issued2018-04-25
dc.date.submitted2018-08-15
dc.identifier.doi10.13028/kx5p-ak35
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26958
dc.description.abstractThis poster evaluates the financial impact of high-cost infused medications across three site of care programs. Site of care programs help payers save money on specialty drug spend by shifting utilization on high costs infused medications to less costly sites of administration. The objective of this project was to evaluate the costs associated with the administration of select high-cost infused medications in site of care programs in Massachusetts Medicaid populations. Research was done through retrospective analysis that included pharmacy and medical claims data for select high cost infused medications between April 1, 2017 - September 20, 2017. This presentation was given at the 2018 Managed Care & Specialty Pharmacy Annual Meeting and received the AMCP Foundation Best Poster Award in the Resident and Fellows category.
dc.language.isoen_US
dc.rights© 2018 University of Massachusetts Medical School
dc.subjectMedicaid
dc.subjectPharmacy
dc.subjectDrug Utilization Review
dc.subjectHealth Economics
dc.subjectHealth Policy
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectPharmaceutical Preparations
dc.subjectPharmacoeconomics and Pharmaceutical Economics
dc.titleA Comparison of the Costs Associated with the Administration of Select High-cost Infused Medications in Three Sites of Care for a State Medicaid Population
dc.typePoster
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1205&context=commed_pubs&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/commed_pubs/189
dc.identifier.contextkey12662549
refterms.dateFOA2022-08-23T15:42:53Z
html.description.abstract<p>This poster evaluates the financial impact of high-cost infused medications across three site of care programs. Site of care programs help payers save money on specialty drug spend by shifting utilization on high costs infused medications to less costly sites of administration. The objective of this project was to evaluate the costs associated with the administration of select high-cost infused medications in site of care programs in Massachusetts Medicaid populations. Research was done through retrospective analysis that included pharmacy and medical claims data for select high cost infused medications between April 1, 2017 - September 20, 2017.</p> <p>This presentation was given at the 2018 Managed Care & Specialty Pharmacy Annual Meeting and received the <a href="https://commed.umassmed.edu/news/2018/04/26/clinical-pharmacy-services-resident-receives-best-poster-award-academy-managed-care">AMCP Foundation Best Poster Award</a> in the Resident and Fellows category.</p>
dc.identifier.submissionpathcommed_pubs/189
dc.contributor.departmentCommonwealth Medicine, Office of Clinical Affairs/MassHealth
dc.contributor.departmentCommonwealth Medicine, Clinical Pharmacy Services
dc.contributor.departmentCommonwealth Medicine, Center for Health Policy and Research


Files in this item

Thumbnail
Name:
UMASS_AMCP_2018_ComparisonCost ...
Size:
377.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record